Drug Quarantine Update
Further to DrugAlert Vol 475, HPS Pharmacies wish to advise that Baxter Healthcare, in consultation with the Therapeutic Goods Administration (TGA), have lifted the drug quarantine status for Baxter Potassium Chloride 10mmol and 0.29% Sodium Chloride 100mL intravenous infusion bags as follows:
Baxter Potassium Chloride and Sodium Chloride Intravenous Infusion
Potassium chloride 10mmol and Sodium Chloride 0.29%
The only batch affected by the quarantine was BN: W66L5 with an expiry date of January 2020.
This drug quarantine status has now been lifted following the successful completion of sterility testing on the contents of 20 bags using the methodology of the British Pharmacopoeia (BP) 2019 Appendix XVI.A Test for Sterility.
Any products placed into quarantine as a result of this issue may now be removed from quarantine and used as per standard protocols.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Baxter on 1800 229 837.